| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |